[Adherence to treatment of hematological malignancies patients with anxiety and depression].

D E Vybornykh T N Moiseeva E G Gemdzhian Tatiana V Gaponova L V Esina E I Kolgaeva D V Novikova

Published in: Terapevticheskii arkhiv (2023)

Anxiety/depressive disorders contribute to reduced adherence of hematologic malignancies patients to treatment. Their correction and increased adherence should be carried out jointly by hematologists and mental health professionals.

Keyphrases

ejection fraction
newly diagnosed
mental health
type diabetes
bipolar disorder
depressive symptoms
stress induced
patient reported